Hepatitis C Virus Epidemiology, Pathogenesis, Diagnosis, and Natural History

  • Author: Francesco Negro, MD (More Info)
  • Editors In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 5/23/18 (What's New)

Summary

  • Several extrahepatic manifestations (Table 3) associated with HCV infection may significantly affect its morbidity and mortality[Negro 2015]
    • The presence of a clinically significant extrahepatic manifestation may sometimes represent a sufficient indication for antiviral therapy
    • Availability of interferon-free regimens provides means of treating HCV-related autoimmune conditions with contraindications to interferon

Action required

Keywords: Hepatitis C, Hepatitis C-Pathogenesis and Natural History

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.